Functional Assay
ERK and FRS2alpha phosphorylation induced by FGF-21 in bKlotho expressing cells. Klotho expressing cells were serum starved for 16 hours and then stimulated with hFGF-21-His (competitor), FGF-21-Fc and FGF-b (positive control) for 10 minutes, respectively. Antibodies against pFRS2alpha, pERK1/2 and total ERK1/2 were used for immunoblotting. Lane 1: 1 ug/ml hFGF21-His (competitor) Lane 2: 2.2 ug/ml hFGF21-Fc (Prod. No. AG-40A-0095) Lane 3: 2.2 ug/ml mCD137-Fc (Prod. No. AG-40A-0025) Lane 4: 100ng/ ul FGF-b Lane 5: control (non-treated)
Functional Assay
ERK and FRS2alpha phosphorylation induced by FGF-21 in bKlotho expressing cells. Klotho expressing cells were serum starved for 16 hours and then stimulated with hFGF-21-His (competitor), FGF-21-Fc and FGF-b (positive control) for 10 minutes, respectively. Antibodies against pFRS2alpha, pERK1/2 and total ERK1/2 were used for immunoblotting. Lane 1: 1 ug/ml hFGF21-His (competitor) Lane 2: 2.2 ug/ml hFGF21-Fc (Prod. No. AG-40A-0095) Lane 3: 2.2 ug/ml mCD137-Fc (Prod. No. AG-40A-0025) Lane 4: 100ng/ ul FGF-b Lane 5: control (non-treated)
Functional Assay
ERK and FRS2alpha phosphorylation induced by FGF-21 in bKlotho expressing cells. Klotho expressing cells were serum starved for 16 hours and then stimulated with hFGF-21-His (competitor), FGF-21-Fc and FGF-b (positive control) for 10 minutes, respectively. Antibodies against pFRS2alpha, pERK1/2 and total ERK1/2 were used for immunoblotting. Lane 1: 1 ug/ml hFGF21-His (competitor) Lane 2: 2.2 ug/ml hFGF21-Fc (Prod. No. AG-40A-0095) Lane 3: 2.2 ug/ml mCD137-Fc (Prod. No. AG-40A-0025) Lane 4: 100ng/ ul FGF-b Lane 5: control (non-treated)
Functional Assay
ERK and FRS2alpha phosphorylation induced by FGF-21 in bKlotho expressing cells. Klotho expressing cells were serum starved for 16 hours and then stimulated with hFGF-21-His (competitor), FGF-21-Fc and FGF-b (positive control) for 10 minutes, respectively. Antibodies against pFRS2alpha, pERK1/2 and total ERK1/2 were used for immunoblotting. Lane 1: 1 ug/ml hFGF21-His (competitor) Lane 2: 2.2 ug/ml hFGF21-Fc (Prod. No. AG-40A-0095) Lane 3: 2.2 ug/ml mCD137-Fc (Prod. No. AG-40A-0025) Lane 4: 100ng/ ul FGF-b Lane 5: control (non-treated)